Skip to main content
. Author manuscript; available in PMC: 2009 Jul 1.
Published in final edited form as: Bone. 2008 Mar 15;43(1):162–168. doi: 10.1016/j.bone.2008.03.003

Table 3.

Characteristics of Fractures in Subjects with Thalassemia, Transfused and Non-Transfused Sickle Cell Disease Subjects by Age Group

Characteristic, Unit Thal a Tx-SCD NonTx-SCD p-value (Thal vs. Tx-SCD) b SCD vs. NonTx-SCD)
Adults, 19+ yrs n=118 n=101 n=41
Fracture Prevalence, N (%) 53 (44.9) 27 (26.7) 12 (29.3) 0.005 NS
 Females 18 (34.0) 13 (20.3) 4 (20.0) NS NS
 Males 35 (53.9) 14 (37.8) 8 (38.1) NS NS
Total number of fractures 95 34 21
Sites of Fracture
 Upper Extremity 53 (55.8) 15 (44.1) 11 (52.4)
 Lower Extremity 29 (30.5) 12 (35.3) 3 (14.3)
 Spine, Back, Pelvis 10 (10.5) 5 (14.7) 4 (19.1)
 Other/undefined 3 (3.2) 2 (5.9) 3 (14.3)
Cause of Fracture
 Fall 54 (56.8) 19 (55.9) 6 (28.6)
 Recreational 20 (21.1) 5 (14.7) 8 (38.1)
 MVA, Object, Other 21 (22.1) 10 (29.4) 7 (33.3)
Adolescents, 1218 yrs n=34 n=102 n=24
Fracture Prevalence, N (%) 6 (17.7) 17 (16.7) 3 (12.5) NS NS
 Females 1 (5.3) 7 (13.7) 1 (8.3) NS NS
 Males 5 (33.3) 10 (19.6) 2 (16.7) NS NS
Total number of fractures 9 18 5
Sites of Fracture
 Upper Extremity 8 (88.9) 8 (44.4) 3 (60.0)
 Lower Extremity 1 (11.1) 7 (38.9) 1 (20.0)
 Other/undefined 0 (0.0) 3 (16.7) 1 (20.0)
Cause of Fracture
 Fall 5 (55.6) 7 (38.9) 3 (60.0)
 Recreational 4 (44.4) 5 (27.8) 1 (20.0)
 MVA or Other 0 (0.0) 6 (33.3) 1 (20.0)
a

THAL: Thalassemic subjects; Tx-SCD: Transfused sickle cell subjects, NonTx-SCD subjects

b

p-values for differences between groups are based on Pearson’s chi-square tests for categorical variables or ANOVA for continuous variables. The p-value for age at splenectomy is determined using Kruskal-Wallis test. Superscripts denote differences between groups at p<0.05 using Pearson’s chi-square tests or Fisher’s exact tests for categorical variables and Mann-Whitney two-sample tests for age at splenectomy.